[go: up one dir, main page]

FI900813A0 - Menetelmä uusien terapeuttisesti käyttökelpoisten bentsatsepiini- ja bentsotiatsepiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten bentsatsepiini- ja bentsotiatsepiinijohdannaisten valmistamiseksi

Info

Publication number
FI900813A0
FI900813A0 FI900813A FI900813A FI900813A0 FI 900813 A0 FI900813 A0 FI 900813A0 FI 900813 A FI900813 A FI 900813A FI 900813 A FI900813 A FI 900813A FI 900813 A0 FI900813 A0 FI 900813A0
Authority
FI
Finland
Prior art keywords
benzazepine
preparation
therapeutically useful
benzothiazepine derivatives
new therapeutically
Prior art date
Application number
FI900813A
Other languages
English (en)
Swedish (sv)
Other versions
FI94246B (fi
FI94246C (fi
Inventor
David M Floyd
John T Hunt
Spencer D Kimball
John Krapcho
Jagabandhu Das
George C Rovnyak
Joel C Barrish
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of FI900813A0 publication Critical patent/FI900813A0/fi
Publication of FI94246B publication Critical patent/FI94246B/fi
Application granted granted Critical
Publication of FI94246C publication Critical patent/FI94246C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
FI900813A 1988-06-20 1990-02-19 Menetelmä uusien terapeuttisesti käyttökelpoisten bentsatsepiini- ja bentsotiatsepiinijohdannaisten valmistamiseksi FI94246C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US20852188A 1988-06-20 1988-06-20
US20852188 1988-06-20
US35380689 1989-05-22
US07/353,806 US4902684A (en) 1988-06-20 1989-05-22 Benzazepine and benzothiazepine derivatives
US8902270 1989-05-23
PCT/US1989/002270 WO1989012633A1 (en) 1988-06-20 1989-05-23 Benzazepine and benzothiazepine derivatives

Publications (3)

Publication Number Publication Date
FI900813A0 true FI900813A0 (fi) 1990-02-19
FI94246B FI94246B (fi) 1995-04-28
FI94246C FI94246C (fi) 1995-08-10

Family

ID=26903265

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900813A FI94246C (fi) 1988-06-20 1990-02-19 Menetelmä uusien terapeuttisesti käyttökelpoisten bentsatsepiini- ja bentsotiatsepiinijohdannaisten valmistamiseksi

Country Status (29)

Country Link
US (1) US4902684A (fi)
JP (1) JP2793674B2 (fi)
KR (1) KR970002633B1 (fi)
CN (1) CN1027262C (fi)
AT (1) AT398567B (fi)
AU (1) AU614399B2 (fi)
BE (1) BE1003305A4 (fi)
CA (1) CA1336975C (fi)
CH (1) CH681723A5 (fi)
EG (1) EG19071A (fi)
ES (1) ES2016467A6 (fi)
FI (1) FI94246C (fi)
FR (1) FR2632953B1 (fi)
GB (1) GB2231329B (fi)
GR (1) GR1002099B (fi)
HU (1) HU210929B (fi)
IE (1) IE64242B1 (fi)
IL (1) IL90515A (fi)
IT (1) IT1230884B (fi)
LU (1) LU87865A1 (fi)
NL (1) NL8920642A (fi)
NO (1) NO179449C (fi)
NZ (1) NZ229612A (fi)
PL (1) PL162313B1 (fi)
PT (1) PT90914B (fi)
RU (1) RU2090562C1 (fi)
SE (1) SE9004060L (fi)
WO (1) WO1989012633A1 (fi)
YU (1) YU121389A (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008284A (en) * 1989-02-15 1991-04-16 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4963671A (en) * 1989-11-20 1990-10-16 E. R. Squibb & Sons, Inc. Process for resolving chiral intermediates used in making calcium channel blockers
US5112969A (en) * 1990-04-02 1992-05-12 Merrell Dow Pharmaceuticals Inc. Cyano esters and azepinones
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato
EP0593603B1 (en) * 1991-06-28 2002-11-20 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
IT1255545B (it) * 1992-10-23 1995-11-09 Procedimento per la preparazione di diltiazem
CA2098446A1 (en) * 1992-09-30 1994-03-31 Eckard Weber 2,5-dihydro-2,5-dioxo-1h-azepines and 2,5-dihydro-2-oxo-1h-azepines and the use thereof as excitatory amino acid and glycine receptor antagonists
ATE216580T1 (de) * 1993-07-16 2002-05-15 Merck & Co Inc Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
EP0751774B1 (en) * 1994-03-24 2003-08-13 Merrell Pharmaceuticals Inc. Hypocholesterolemic mercaptoacetylamide disulfide derivatives
US5580867A (en) * 1994-09-09 1996-12-03 Universite De Montreal Myocardial protection during ischemia and reperfusion
GB9423172D0 (en) 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines
WO1998025920A1 (en) * 1996-12-10 1998-06-18 Abbott Laboratories 3-pyridyl enantiomers and their use as analgesics
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
GB9907895D0 (en) * 1999-04-08 1999-06-02 Texas A & M Univ Sys Novel ligands for chiral catalysis
US6472533B1 (en) 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis
CA2482320C (en) * 2002-04-19 2010-02-09 Georg T. Wondrak Methods for modulating phototoxicity
TWI289141B (en) * 2003-03-11 2007-11-01 Hoffmann La Roche F. Ag. Quinolinone derivatives and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312691A (en) * 1963-08-23 1967-04-04 Ciba Geigy Corp 2, 3, 4, 5-tetrahydro-1-benzazepin-2-ones
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS59191036A (ja) * 1983-04-14 1984-10-30 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
GB2154578A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co Novel 1,5-benzothiazepine derivatives and processes for preparing the same
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
GB2154577A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co 1,5-benzothiazepines
GB2167063A (en) * 1984-11-17 1986-05-21 Tanabe Seiyaku Co 6 or 9-chloro-1, 5-benzothiazepine derivatives
CA1271747A (en) * 1985-06-12 1990-07-17 David M. Floyd Benzazepines derivatives
US4748239A (en) * 1985-06-12 1988-05-31 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1271748C (en) * 1985-12-12 1990-07-17 BENZAZEPINE DERIVATIVES
FR2597097B1 (fr) * 1986-04-15 1988-12-02 Synthelabo Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
EP0256888B1 (en) * 1986-08-20 1991-07-03 McNeilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
US4729994A (en) * 1986-08-20 1988-03-08 Mcneilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
US4694002A (en) * 1986-08-21 1987-09-15 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US4752645A (en) * 1986-10-09 1988-06-21 E. R. Squibb & Sons, Inc. Benzazepine derivatives
ZA893392B (en) * 1988-05-24 1990-01-31 Hoffmann La Roche Process for the manufacture of optically active naphthothiazepinones

Also Published As

Publication number Publication date
HU894298D0 (en) 1991-01-28
FI94246B (fi) 1995-04-28
FR2632953B1 (fr) 1992-05-29
NO905485D0 (no) 1990-12-19
PL162313B1 (pl) 1993-09-30
GB2231329A (en) 1990-11-14
FI94246C (fi) 1995-08-10
NZ229612A (en) 1992-07-28
ES2016467A6 (es) 1990-11-01
CN1027262C (zh) 1995-01-04
KR920700207A (ko) 1992-02-19
BE1003305A4 (fr) 1992-02-25
IE64242B1 (en) 1995-07-26
PT90914B (pt) 1994-12-30
IL90515A (en) 1994-07-31
NL8920642A (nl) 1990-06-01
YU121389A (en) 1991-04-30
ATA901089A (de) 1994-05-15
RU2090562C1 (ru) 1997-09-20
LU87865A1 (de) 1991-12-16
IT8920933A0 (it) 1989-06-20
CN1039585A (zh) 1990-02-14
AU3859389A (en) 1990-01-12
PT90914A (pt) 1989-12-29
IE891957L (en) 1989-12-20
SE9004060L (sv) 1992-06-20
SE9004060D0 (sv) 1990-12-19
AU614399B2 (en) 1991-08-29
US4902684A (en) 1990-02-20
CA1336975C (en) 1995-09-12
GB9002587D0 (en) 1990-08-29
NO905485L (no) 1991-02-19
CH681723A5 (fi) 1993-05-14
WO1989012633A1 (en) 1989-12-28
JPH04502002A (ja) 1992-04-09
NO179449C (no) 1996-10-09
GR1002099B (en) 1995-12-28
HUT59908A (en) 1992-07-28
IT1230884B (it) 1991-11-08
NO179449B (no) 1996-07-01
GR890100410A (el) 1990-05-11
IL90515A0 (en) 1990-01-18
GB2231329B (en) 1992-10-21
EG19071A (en) 1994-07-30
JP2793674B2 (ja) 1998-09-03
KR970002633B1 (en) 1997-03-06
HU210929B (en) 1995-09-28
AT398567B (de) 1994-12-27
FR2632953A1 (fr) 1989-12-22

Similar Documents

Publication Publication Date Title
FI881900A7 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten substituoitujen imidatsolyylialkyylipiperatsiini- ja -diatsepiinijohdannaisten valmistamiseksi
FI900813A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bentsatsepiini- ja bentsotiatsepiinijohdannaisten valmistamiseksi
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI905941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI875660L (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi
FI875024A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-alkyyli-6-halogeenitetrahydronaftaleenijohdannaisten valmistamiseksi
FI883739A7 (fi) Menetelmä terapeuttisesti aktiivisten fenoksi-indaanimetyyliamiinijohdannaisten valmistamiseksi
FI892682A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
NO175478C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater
FI890072A7 (fi) Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi
FI923527L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi
FI895417A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-halometylideeninukleosidien valmistamiseksi
FI95570C (fi) Menetelmä lääkinnällisesti vaikuttavien pyridatsinoni-3(2H)-onijohdannaisten valmistamiseksi
FI891003A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-substituoitujen purinyylipiperatsiinijohdannaisten valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI884553A7 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
FI894604L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridyyli- ja pyrimidyylipiperatsiinijohdannaisten valmistamiseksi
FI904838A7 (fi) Menetelmä farmaseuttisesti aktiivisten karboksitetrahydroisokinoliinien ja niiden johdannaisten valmistamiseksi
FI912124A7 (fi) Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
FI890186A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI890185A7 (fi) Menetelmä 1-alkyyli-5-nitroimidatsolien valmistamiseksi
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: E.R. SQUIBB & SONS, INC.